Managing erythropoietin hyporesponsiveness

The anemia of chronic kidney disease is associated with cardiovascular disease, decreased quality of life, and mortality. The introduction of recombinant human erythropoietin (rHuEPO) has transformed the management of this condition. However, a significant proportion of patients fail to respond to e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Seminars in dialysis 2006-03, Vol.19 (2), p.146
Hauptverfasser:	Kwack, Christina, Balakrishnan, Vaidyanathapuram S
Format:	Artikel
Sprache:	eng
Schlagworte:	Aluminum - blood Anemia - drug therapy Anemia - etiology Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - pharmacology Avitaminosis - complications Carnitine - deficiency Erythropoietin - therapeutic use Humans Hyperparathyroidism - complications Inflammation - complications Kidney Failure, Chronic - therapy Oxidative Stress Recombinant Proteins Renal Dialysis - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!